Navidea Announces Clinical Data for Manocept Shows Agent Localizes in Multiple KS Lesions

By: via Benzinga
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) and its subsidiary, Macrophage Therapeutics, Inc., today announced that imaging results ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.